Document is current
Any future updates will be listed below
-
Authors
Carl, Nicolas
Schramm, Franziska
Haggenmüller, Sarah
Kather, Jakob Nikolas
Hetz, Martin J.
Wies, Christoph https://orcid.org/0000-0001-7136-298X
Michel, Maurice Stephan
Wessels, Frederik https://orcid.org/0000-0003-4213-8692
Brinker, Titus J. https://orcid.org/0000-0002-3620-5919
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 12 October 2024
First Online: 23 October 2024
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: T.J.B. would like to disclose that he is the owner of Smart Health Heidelberg GmbH (Handschuhsheimer Landstr. 9/1, 69120 Heidelberg, Germany; ), outside the submitted work. F.W. would like to disclose that he advises Janssen, AstraZeneca, and Adon Health outside the submitted work. J.N.K. would like to disclose consulting services for Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Scailyte, Switzerland; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, has received a research grant from GSK, and has received honoraria from AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. J.N.K. is Deputy Editor at npj Precision Oncology, but did not have a role in the editorial assessment of this article. The other authors have no competing interests to declare.
